CRBP - コ―バス・ファ―マシュ―ティカルズ (Corbus Pharmaceuticals Holdings Inc.) コ―バス・ファ―マシュ―ティカルズ

 CRBPのチャート


 CRBPの企業情報

symbol CRBP
会社名 Corbus Pharmaceuticals Holdings Inc (コ―バス・ファ―マシュ―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 コールバス・ファーマシューティカルズ・ホールディングス(Corbus Pharmaceuticals Holdings Inc.)は臨床段階の製薬会社である。同社は希少・慢性・深刻炎症性及び線維性疾患を治療するための治療薬の開発・商品化に焦点を当てる。同社は希少な生命を脅かす炎症性線維症疾患の治療薬の開発・商品化を通じて事業を運営する。同社の製品であるlenabasumは慢性炎症を解消し、線維化過程を止めるように設計された合成経口エンドカンナビノイド模倣薬である。lenabasumは内因性経路を活性化することによって炎症を解消し、線維化を停止させるように作用する専門化されたプロ解消脂質メディエーター(SPM)の生産を促進する。同社は全身性硬化症、嚢胞性線維症、びまん性皮膚疾患、皮膚優性皮膚筋炎及び全身性エリテマトーデス(SLE)の4つの疾患を治療するためのlenabasumを開発する。   コ―バス・ファ―マシュ―ティカルズは炎症性線維症の治療薬の開発と商品化に焦点を置く米国のバイオ医薬品会社。第2相臨床試験を行う「リスナブ」は嚢胞性線維症と硬皮症の治療用の経口抗炎症剤。「リスナブ」はカンナビノイド受容体(CB2)を活性化し、抗炎性物質の放出を促進するとともに、炎症性物質の放出とサイトカインの分泌を抑制。   
本社所在地 500 River Ridge Drive Norwood MA 02062 USA
代表者氏名 Mark A. Tepper マークA.テッパー
代表者役職名 President Chief Scientific Officer
電話番号 +1 617-963-0103
設立年月日
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 47人
url www.corbuspharma.com
nasdaq_url https://www.nasdaq.com/symbol/crbp
adr_tso
EBITDA EBITDA(百万ドル) -41.67992
終値(lastsale) 6.79
時価総額(marketcap) 388429351.1
時価総額 時価総額(百万ドル) 396.43820
売上高 売上高(百万ドル) 2.60040
企業価値(EV) 企業価値(EV)(百万ドル) 331.84536
当期純利益 当期純利益(百万ドル) -41.42403
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Corbus Pharmaceuticals Holdings Inc revenues increased 10% to $1.8M. Net loss increased 61% to $23.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development increase of 65% to $20M (expense) General and administrative increase of 42% to $6M (expense).

 CRBPのテクニカル分析


 CRBPのニュース

   Cannabis Stock Gainers And Losers From December 18, 2020  2020/12/18 22:46:56 Benzinga
GAINERS: Origin Agritech (NASDAQ: SEED ) shares closed up 20.61% at $13.87 Marrone Bio Innovations (NASDAQ: MBII ) shares closed up 15% at $1.38 Item 9 Labs (OTCQX: INLB ) shares closed up 11.39% at $2.25 Corbus Pharmaceuticals (NASDAQ: CRBP ) shares closed up 11.11% at $1.50 BioHarvest Sciences (OTC: CNVCF) shares closed up 10.35% at $0.14 Cansortium (OTCQB: CNTMF ) shares closed up 8.98% at $0.45 Empower Clinics (OTC: EPWCF ) shares closed up 7.53% at $0.23 ReneSola (NYSE: Full story available on Benzinga.com
   72 Biggest Movers From Yesterday  2020/12/02 09:58:21 Benzinga
Gainers Auris Medical Holding Ltd. (NASDAQ: EARS ) shares jumped 371% to close at $5.23 on Tuesday after the company reported positive efficacy data for its AM-301 in protecting against Sars Covid-19 infections. Corporación América Airports S.A. (NYSE: CAAP ) shares surged 43% to close at $4.49 on Tuesday after the company reported an agreement to extend the Aeropuertos Argentina 2000 concession for 10-years until 2038. Arlo Technologies Inc (NYSE: ARLO ) jumped 31.2% to close at $6.90. Traders are circulating link on Apple Store showing Arlo Ultra 4K wire-free security cameras sold by Apple.. Jaguar Health, Inc. (NASDAQ: JAGX ) shares climbed 30.9% to close at $0.4580 on Tuesday. Jaguar Health shares jumped over 66% on Monday after the company announced plans to develop and commercialize its Crofelemer. CollPlant Biotechnologies Ltd. (NASDAQ: CLGN ) rose 29% to close at $10.23 after the company swung to a profit in the latest quarter. Onconova Therapeutics, Inc. (NASDAQ: ONTX ) shares surged 28.5% to close at $0.3725 after climbing over 11% on Monday.
   Cannabis Stock Gainers And Losers From December 1, 2020  2020/12/01 22:39:22 Benzinga
GAINERS: CURE Pharmaceutical Hldg (OTCQB: CURR ) shares closed up 32.26% at $1.64 Corbus Pharmaceuticals (NASDAQ: CRBP ) shares closed up 18.85% at $1.45 4Front Ventures (OTCQX: FFNTF ) shares closed up 9.82% at $0.85 EnWave (PINK: NWVCF ) shares closed up 9.05% at $0.89 Teradyne (NASDAQ: TER ) shares closed up 4.33% at $115.12 GreenTree Hospitality Gr (NYSE: GHG ) shares closed up 4% at $12.23 Full story available on Benzinga.com
   Thinking about buying stock in Titan Pharmaceuticals, Moderna, Moleculin Biotech, Corbus Pharmaceuticals, or Altimmune?  2020/12/01 13:30:00 PR Newswire
NEW YORK, Dec. 1, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TTNP, MRNA, MBRX, CRBP, and ALT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Corbus Pharmaceuticals (NASDAQ:CRBP) Announces Earnings Results, Meets Expectations  2020/11/17 13:45:18 Transcript Daily
Corbus Pharmaceuticals (NASDAQ:CRBP) issued its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.42) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.42), Fidelity Earnings reports. Corbus Pharmaceuticals had a negative return on equity of 485.45% and a negative net margin of 2,208.06%. CRBP stock opened at $1.22 on Tuesday. […]
   Corbus Pharma plans workforce reduction by 54% to advance clinical programs (NASDAQ:CRBP)  2020/10/08 13:07:35 Seeking Alpha
Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) announces restructuring by reduction its workforce by 54% to reallocate capital to certain clinical and precl
   The Daily Biotech Pulse: Bristol-Myers Squibb's Lung Cancer Readout, Positive News From Masimo, Integra Lifesciences  2020/10/07 11:30:09 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) 10X Genomics Inc (NASDAQ: TXG ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) CareDx Inc (NASDAQ: CDNA ) Castle Biosciences Inc (NASDAQ: CSTL ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CTI BioPharma Corp (NASDAQ: CTIC ) CymaBay Therapeutics Inc (NASDAQ: CBAY ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Fate Therapeutics Inc (NASDAQ: FATE ) Inspire Medical Systems Inc (NYSE: INSP ) InVitae Corp (NYSE: NVTA ) Kura Oncology Inc (NASDAQ: KURA ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Novocure Ltd (NASDAQ: NVCR ) Pacific Biosciences of California Inc (NASDAQ: PACB ) Prelude Therapeutics Inc (NASDAQ: PRLD ) ProPhase Labs Inc (NASDAQ: PRPH ) Qiagen NV (NYSE: QGEN ) Repligen Corporation (NASDAQ: RGEN ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Turning Point Therapeutics Inc (NASDAQ: TPTX ) Twist Bioscience Corp (NASDAQ: TWST ) Vericel Corp (NASDAQ: VCEL ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Oct. 6) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP ) (reacted to negative results for a mid-stage study of lenabasum in cystic fibrosis patients) Dyne Therapeutics Inc (NASDAQ: DYN ) Outset Medical Inc (NASDAQ: OM ) Teligent Inc (NASDAQ: TLGT ) Stocks In Focus Integra LifeSciences' Preliminary Q3 Revenues Exceed Estimate Medtech company Integra Lifesciences Holdings Corp (NASDAQ: IART ) preannounced third-quarter results, expecting revenues of $368 million to $370 million, down about 2.7%, but exceeding the company's guidance provided at …
   Cannabis Stock Gainers And Losers From September 29, 2020  2020/09/29 21:09:24 Benzinga
GAINERS: 48North Cannabis (PINK: NCNNF ) shares closed up 27.27% at $0.14 Corbus Pharmaceuticals (NASDAQ: CRBP ) shares closed up 20.12% at $1.97 GrowGeneration (NASDAQ: GRWG ) shares closed up 9.13% at $16.02 Aleafia Health (OTCQX: ALEAF ) shares closed up 7.71% at $0.37 CV Sciences (OTCQB: CVSI ) shares closed up 7.57% at $0.54 Marrone Bio Innovations (NASDAQ: MBII ) shares closed up 6.78% at $1.26 Item 9 Labs (OTCQX: INLB ) shares closed up 1.33% at $6.4 BioHarvest Sciences (OTC: CNVCF) shares closed up … Full story available on Benzinga.com
   Cannabis Stock Gainers And Losers From September 9, 2020  2020/09/09 22:10:36 Benzinga
Gainers: AusCann Group Holdings (OTC: ACNNF ) shares closed up 24.11% at $0.12 Heritage Cannabis Holding (OTC: HERTF ) shares closed up 18.04% at $0.08 NexTech AR Solns (OTC: NEXCF ) shares closed up 13.42% at $4.09 Cann Gr (OTC: CNGGF ) shares closed up 10.34% at $0.32 Corbus Pharmaceuticals (NASDAQ: CRBP ) shares closed up 9.42% at $2.44 Emerald Health (OTC: EMHTF ) shares closed up 8.74% at $0.17 Bloom Energy (NYSE: BE ) … Full story available on Benzinga.com
   The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment  2020/09/09 11:23:14 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Akouos Inc (NASDAQ: AKUS ) Albireo Pharma Inc (NASDAQ: ALB )(announced positive Phase 3 results for odevixibat in a liver disorder called progressive familial intrahepatic cholestasis) Castle Biosciences Inc (NASDAQ: CSTL ) Harmony Biosciences Holdings Inc (NASDAQ: HRMY ) Kura Oncology Inc (NASDAQ: KURA ) Merit Medical Systems, Inc. (NASDAQ: MMSI )(announced sale of manufacturing equipment and associated assets used in its hypotube manufacturing business) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 8) ADiTx Therapeutics Inc (NASDAQ: ADTX ) AEterna Zentaris Inc. (NASDAQ: AEZS )(announced the presentation of data from pediatric study of macimorelin for childhood-onset growth hormone deficiency) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Ayala Pharmaceuticals Inc (NASDAQ: AYLA ) Burning Rock Biotech Ltd (NASDAQ: BNR ) Checkmate Pharmaceuticals Inc (NASDAQ: CMPI ) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP )( reacted to a negative data readout) Immatics NV (NASDAQ: IMTX ) Kymera Therapeutics Inc (NASDAQ: KYMR ) Legend Biotech Corp (NASDAQ: LEGN ) Regulus Therapeutics Inc (NASDAQ: RGLS ) Royalty Pharma plc (NASDAQ: RPRX ) Second Sight Medical Products Inc (NASDAQ: EYES ) Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS ) Viveve Medical Inc (NASDAQ: VIVE ) Stocks In Focus AstraZeneca Halts Coronavirus Vaccine Study to Allow For Safety Review Following an Unexplained Illness AstraZeneca plc (NYSE: AZN ) shares are under pressure after the company said in a statement to STATNews it has voluntarily paused the study of the coronavirus vaccine candidate it is jointly developing with the Oxford University in order to allow review of safety data by an independent committee.
   Corbus Pharmaceuticals secures debt funding of $50M (NASDAQ:CRBP)  2020/07/29 13:15:12 Seeking Alpha
Corbus Pharmaceuticals (NASDAQ:CRBP) +6%, after the company has announced debt financing facility with K2 HealthVentures of $50M. The company received the
   Corbus Pharmaceuticals Strengthens Balance Sheet with up to $121 Million in New Capital | MarketScreener  2020/07/29 12:06:01 MarketScreener
Aggregate of $71 million of ATM proceeds executed at weighted average price of $7.70 per shareReceived $20 million first tranche from $50 million debt facility with K2 HealthVentures Cash on… | July 29, 2020
   Corbus Pharmaceuticals Strengthens Balance Sheet with up to $121 Million in New Capital  2020/07/29 12:05:00 GlobeNewswire
Aggregate of $71 million of ATM proceeds executed at weighted average price of $7.70 per shareReceived $20 million first tranche from $50 million debt…
   Corbus Pharmaceuticals Is an Example of How I'm Playing an Uncertain Market  2020/07/24 12:52:48 The Street RealMoney
CRBP has topline Phase 3 data for its primary compound Lenabasum for Systemic Sclerosis due out this summer….AMZN
   Corbus Pharma is nearing the readout of a pivotal drug study  2020/07/17 08:40:31 STAT News
Here's what you need to know about the Corbus Pharmaceuticals drug, the study design, and the expectations for the readout.

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 コ―バス・ファ―マシュ―ティカルズ CRBP Corbus Pharmaceuticals Holdings Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)